Basic Information
RNALocate ID: | RLID-D:11000683 |
RNA Symbol: | hsa-miR-146b-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-146b-3p |
RNA ID: | miRBase:MIMAT0004766 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003976 | Exosome | Pulmonary epithelial cell line (BEAS-2B) | 31520698 |
RLID:11003977 | Exosome | Plasma | 23663360 |
RLID-D:11000205 | Exosome | Mast cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-146b-3p | Ovarian clear cell carcinoma | MNDR-E-MI-15530 |
MNDR | hsa-miR-146b-3p | Lymphoma | MNDR-E-MI-15531 |
MNDR | hsa-miR-146b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15532 |
MNDR | hsa-miR-146b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-15533 |
MNDR | hsa-miR-146b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15534 |
MNDR | hsa-miR-146b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15535 |
MNDR | hsa-miR-146b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-15536 |
MNDR | hsa-miR-146b-3p | Gastric cancer | MNDR-E-MI-15537 |
MNDR | hsa-miR-146b-3p | Alzheimer disease | MNDR-E-MI-15538 |
MNDR | hsa-miR-146b-3p | Dysautonomia familial | MNDR-E-MI-15539 |
MNDR | hsa-miR-146b-3p | Lung cancer | MNDR-E-MI-15540 |
MNDR | hsa-miR-146b-3p | Parkinson disease | MNDR-E-MI-15541 |
MNDR | hsa-miR-146b-3p | Breast cancer | MNDR-E-MI-15542 |
MNDR | hsa-miR-146b-3p | Pancreatic cancer | MNDR-E-MI-15543 |
MNDR | hsa-miR-146b-3p | Melanoma | MNDR-E-MI-15544 |
MNDR | hsa-miR-146b-3p | Rectum adenocarcinoma | MNDR-E-MI-15545 |
MNDR | hsa-miR-146b-3p | Nephroblastoma | MNDR-E-MI-15546 |
MNDR | hsa-miR-146b-3p | Colon cancer | MNDR-E-MI-15547 |
MNDR | hsa-miR-146b-3p | Colon adenocarcinoma | MNDR-E-MI-15548 |
MNDR | hsa-miR-146b-3p | Prostate adenocarcinoma | MNDR-E-MI-15549 |
MNDR | hsa-miR-146b-3p | Carcinoma ductal breast | MNDR-E-MI-15550 |
MNDR | hsa-miR-146b-3p | Malignant glioma | MNDR-E-MI-15551 |
MNDR | hsa-miR-146b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-15552 |
MNDR | hsa-miR-146b-3p | Temporal lobe epilepsy | MNDR-E-MI-15553 |
MNDR | hsa-miR-146b-3p | Osteosarcoma | MNDR-E-MI-15554 |
MNDR | hsa-miR-146b-3p | Gastric adenocarcinoma | MNDR-E-MI-15555 |
MNDR | hsa-miR-146b-3p | Lung squamous cell carcinoma | MNDR-E-MI-15556 |
MNDR | hsa-miR-146b-3p | Lung adenocarcinoma | MNDR-E-MI-15557 |
MNDR | hsa-miR-146b-3p | Thyroid carcinoma | MNDR-E-MI-15558 |
MNDR | hsa-miR-146b-3p | Papillary thyroid carcinoma | MNDR-E-MI-15559 |
MNDR | hsa-miR-146b-3p | Bladder urothelial carcinoma | MNDR-E-MI-15560 |
MNDR | hsa-miR-146b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-15561 |
MNDR | hsa-miR-146b-3p | Carcinoma renal cell | MNDR-E-MI-15562 |
MNDR | hsa-miR-146b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15563 |
MNDR | hsa-miR-146b-3p | Renal clear cell carcinoma | MNDR-E-MI-15564 |
MNDR | hsa-miR-146b-3p | Cholangiocarcinoma | MNDR-E-MI-15565 |
MNDR | hsa-miR-146b-3p | Breast invasive carcinoma | MNDR-E-MI-15566 |
MNDR | hsa-miR-146b-3p | Hepatocellular carcinoma | MNDR-E-MI-15567 |
MNDR | hsa-miR-146b-3p | Rheumatoid arthritis | MNDR-E-MI-15568 |
MNDR | hsa-miR-146b-3p | Malignant pleural mesothelioma | MNDR-E-MI-15569 |
MNDR | hsa-miR-146b-3p | Neuromyelitis optica | MNDR-E-MI-15570 |
MNDR | hsa-miR-146b-3p | Skin cutaneous melanoma | MNDR-E-MI-15571 |
MNDR | hsa-miR-146b-3p | Skin melanoma | MNDR-E-MI-15572 |
MNDR | hsa-miR-146b-3p | Colorectal cancer | MNDR-E-MI-15573 |
MNDR | hsa-miR-146b-3p | Epstein-barr virus infections | MNDR-E-MI-15574 |
MNDR | hsa-miR-146b-3p | Breast cancer her3+ negative | MNDR-E-MI-15575 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | PDGFB | Homo sapiens | RR01079672 |
TOP